Volume 1.06 | Feb 19

Prostate Cell News 1.06, February 19, 2010.
In this issue: Science News  |  Current Publications  |  Industry News  |  Policy News  |  Events Subscribe  |  Unsubscribe


Low Levels of Phosphorylated Epidermal Growth Factor Receptor in Nonmalignant and Malignant Prostate Tissue Predict Favorable Outcome in Prostate Cancer Patients
Low phosphorylated epidermal growth factor receptor immunoreactivity is associated with the favorable prognosis in prostate cancer patients and may provide information about which patients with Gleason score 6 and 7 tumors that will survive their disease even without treatment. [Clin Cancer Res]




Small Liquid Sensor May Detect Cancer Instantly, Could Lead to Home Detection Kit
A researcher is developing a tiny sensor, known as an acoustic resonant sensor, that is smaller than a human hair and could test bodily fluids for a variety of diseases, including breast and prostate cancers. [University of Missouri Press Release]

Britain’s Youngest Prostate Cancer Sufferer at Seven Months Old Cured by Pioneering Therapy
Britain’s youngest victim of prostate cancer has been given the all clear by medics after pioneering treatment in America. [The Daily Mail]

Watch Procedure Now  
Optimized Enzymes and Protocols for
Prostate Tissue Dissociation

by STEMCELL Technologies



Post-Transcriptional Regulation of Androgen Receptor mRNA by an ErbB3 Binding Protein 1 in Prostate Cancer
Here, researchers show that EBP1 promoted androgen receptor (AR) mRNA decay through physical interaction with a conserved UC-rich motif within the 3′-UTR of AR. [Nucleic Acids Res]

A Novel Role for PIAS Proteins in Modulating the Activity of Zimp7, a Novel PIAS-Like Protein, on the Androgen Receptor-Mediated Transcription
The results demonstrate a novel interaction between PIAS and PIAS-like proteins and elucidate a novel regulatory mechanism for PIAS proteins on androgen receptor mediated transcription. [J Biol Chem]

Eleven-Nineteen Lysine-Rich Leukemia is an HIF-1(alpha) Partner that Regulates and Responds to Hypoxia Response in PC3 Cells
Findings suggest that eleven-nineteen lysine-rich leukemia and HIF-1alpha are binding partners and can modulate the functions of each other in hypoxia. [Prostate]

Snail Transcription Factor Regulates Neuroendocrine Differentiation in LNCaP Prostate Cancer Cells
Overall, data provide evidence that Snail transcription factor may promote tumor aggressiveness in the LNCaP cells through multiple processes; induction of epithelial-mesenchymal transition may be required to promote migration, while neuroendocrine differentiation may promote tumor proliferation by a paracrine mechanism. [Prostate

Association of Hepsin Gene Variants with Prostate Cancer Risk and Prognosis
There was no evidence of altered risks of tumor recurrence/progression or prostate cancer death associated with variants in the hepsin gene. [Prostate

Differential Expression of the Alpha2 Chain of the Interleukin-13 Receptor in Metastatic Human Prostate Cancer ARCaP(M) Cells
Differential expression of the alpha2 chain of the interleukin-13 receptor may account for the high tumorigenic and metastatic potential of ARCaP(M) cells. [Prostate

Effect of Intermittent Fasting with or without Caloric Restriction on Prostate Cancer Growth and Survival in SCID Mice
This exploratory study found non-significant trends toward improved survival with some intermittent fasting regimens, in the absence of weight loss. [Prostate]

Differential Regulation of Steroid Nuclear Receptor Coregulator Expression Between Normal and Neoplastic Prostate Epithelial Cells
Data indicate differences in the regulation of coregulator expression between neoplastic and normal prostate cells. These findings emphasize the important potential of targeting the mechanisms regulating coregulator expression for therapeutic intervention in prostate cancer. [Prostate]
Inhibition of DHCR24/Seladin-1 Impairs Cellular Homeostasis in Prostate Cancer
Seladin-1 involvement in proliferation and secretion suggests that its downregulation may be a major mechanism causing prostate cancer evolution. Seladin-1 may thus potentially decrease cell growth and steroid dependency in low-grade prostate cancer. [Prostate]


Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer
This trial evaluated the efficacy and safety of abiraterone acetate (AA) in combination with prednisone to reduce the symptoms of secondary hyperaldosteronism that can occur with AA monotherapy. [J Clin Oncol

Predictive Factors for Positive Surgical Margins and Their Locations After Robot-Assisted Laparoscopic Radical Prostatectomy
Researchers sought to identify predictive factors for positive surgical margins and their locations after robot-assisted laparoscopic radical prostatectomy. [Eur Urol]

Phase II Trial of Weekly Intravenous 1,25 Dihydroxy Cholecalciferol (Calcitriol) in Combination with Dexamethasone for Castration-Resistant Prostate Cancer
High-dose, iv calcitriol at a dose of 74 mug weekly in combination with dexamethasone was well tolerated but failed to produce a clinical or prostate-specific antigen response in men with castration-resistant prostate cancer. [Cancer

Health Disparities in Staging of SEER-Medicare Prostate Cancer Patients in the United States
Multivariable logistic regression models examined race and age disparities with respect to the odds of being staged among prostate cancer patients using surveillance, epidemiology, and end results-medicare data. [Urology]

Androgens, Growth Factors, and Risk of Prostate Cancer: The Multiethnic Cohort
Researchers conducted a nested case-control study of biomarkers of prostate cancer risk within the Multiethnic Cohort. [Prostate]


Johnson & Johnson’s Drug Helps in Last-Ditch Prostate Cancer Fight
Johnson & Johnson’s experimental drug abiraterone can help men with advanced prostate cancer who have run out of standard treatments options, according to results of a mid-stage clinical trial. [Reuters]

Victoria Prostate Groups Team Up to Boost Efficiency
To cut costs and boost performance, two local prostate cancer groups are joining forces.  The Prostate Centre and Vancouver Island Prostate Cancer Research Foundation have united under the Prostate Centre umbrella with psychologist Jim Ricks as chairman. [Victoria Times Colonist]

Cancer Test Firm DiagnoCure Cutting About 10 Jobs to Preserve Cash
DiagnoCure Inc. is cutting about 10 jobs as the developer of cancer-screening tests moves to preserve cash while it brings its latest tests for colorectal and prostate cancer to market. [The Canadian Press]

Jim Huber to Serve as National Spokesman for ‘Know Your Score: Fight Prostate Campaign’
Award-winning journalist and television personality Jim Huber will serve as the 2010 national spokesman of the “Know Your Score: Fight Prostate Cancer” Celebrity Golf Tournament and Gala scheduled August 28, 2010 in Myrtle Beach, S.C. [PR Newswire]



Portland Development Commission Spends $800,000 for Bioscience ‘Wet Labs’
Oregon’s biotech community will soon have access to four wet labs, where early stage companies can test and analyze chemicals and drugs. [Portland Business Journal]

Food and Drug Administration Budget Draws Cries of ‘Not Enough’
A coalition of interests will push for more money, saying chronic underfunding has led to failures at the agency and that society, not just companies, are affected. [Food and Drug Administration, United States]

Waivers for Conflicts of Interest for the February 22, 2010 Vaccines and Related Biological Products Advisory Committee Meeting [Center for Biologics Evaluation and Research, United States]

Delays in Grant Application Submission due to Widespread Winter Storm (NOT-OD-10-061) [National Institutes of Health, United States]

Recovery Act Limited Competition: Program to Enhance National Institutes of Health-Supported Global Health Research Involving Human Subjects (S07) (RFA-OD-10-006) [National Institutes of Health, United States]

Institutional Clinical and Translational Science Award (U54) (RFA-RM-10-001) [National Institutes of Health, United States]

IACUC 101 Workshop and PRIM&R 2010 IACUC Conference: March 21-23, 2010 in Baltimore, MD (NOT-OD-10-059) [National Institutes of Health, United States]

Notice of Intent to Establish a New National Institutes of Health Common Fund Program: Library of Integrated Network-Based Cellular Signatures (LINCS) (NOT-RM-10-002) [National Institutes of Health, United States]

Investigator Initiated Multi-Site Clinical Trials (Collaborative R01) (PAR-10-096) [National Institutes of Health, United States]

Expressions of Interest for Membership of the Therapeutic Goods Committee [Therapeutic Goods Administration, Australia]


Third International Symposium on Focal Therapy and Imaging of Prostate and Kidney Cancer
February 24-27, 2010
Washington, DC, United States

The 3rd World Congress on Controversies in Urology (CURy)
February 25-28, 2010
Athens, Greece

2010 Genitourinary Cancers Symposium: Progress in Multidisciplinary Management
March 5-7, 2010
San Francisco, United States

American Association for Cancer Research (AACR) 101st Annual Meeting
April 17-21, 2010
Washington, DC, United States

International Society for Stem Cell Research (ISSCR) 8th Annual Meeting
June 16-19, 2010
San Francisco, United States

United Kingdom National Stem Cell Network (UKNSCN) Third Annual Scientific Conference
July 12-14, 2010
Nottingham, United Kingdom

Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.



Manufacturing Sciences Technologist – Cell Culture (STEMCELL Technologies)

Research & Development Technologist (STEMCELL Technologies)

Recruit Top Talent

Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News.
Visit here to post your career opportunities.



Have we missed an important article or publication in Prostate Cell News? Click here to submit!


Learn more about Prostate Cell News: Archives  |  Events  |  Subscribe  |  Contact Us